QTTB FY 2021 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$34M+1157.3% YoY

Gross Profit

$24M71.9% margin

Operating Income

-$96M-282.4% margin

Net Income

-$96M-281.9% margin

EPS (Diluted)

$-12.23

Cash Flow

Operating Cash Flow

-$110M

Free Cash Flow

-$112M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$212M

Total Liabilities

$42M

Stockholders' Equity

$170M

Cash & Equivalents

$108M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$3M	+1157.3%
Gross Profit	$24M	$3M	+804.0%
Operating Income	-$96M	-$130M	+26.3%
Net Income	-$96M	-$129M	+25.6%